Prosomnus announced Nov. 2, 2022, that it received FDA 510(k) clearance for its ProSomnus EVO [PH] sleep and snore device, a precision oral appliance therapy (OAT) device. The ProSomnus EVO [PH] sleep and snore device is intended to reduce nighttime snoring and mild to moderate obstructive sleep apnea in adults.